PERCHERON THERAPEUTICS LIMITED

0.00%

0.8¢

Market Cap $8.699M

Healthcare Biotechnology

Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a... Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The Company is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Latest Threads

Tag

Subject

PER

Ann: Topline Six-Month Results From Phase IIb Study of Avicursen

2 3 4

22/07/25

200

93K

22/07/25

Last post Cuprum29

200

93K

PER

Ann: Percheron licenses HMBD-002 from Hummingbird Bioscience

21/07/25

21K

21/07/25

Last post Motors

21K

PER

Ann: Change of Director's Interest Notice - Dr James Garner

03/07/25

4.8K

03/07/25

Last post dazatoN

4.8K

PER

Ann: Ceasing to be a substantial holder from PVL

30/06/25

1.9K

30/06/25

Last post Motors

1.9K

PER

Ann: Percheron Therapeutics Limited Corporate Presentation

27/06/25

2.4K

27/06/25

Last post joe76

2.4K

PER

Ann: Trading Halt

25/06/25

4.2K

25/06/25

Last post Uboy

4.2K

PER

Ann: Quarterly Activities Report and Appendix 4C

25/06/25

8.3K

25/06/25

Last post Sander51

8.3K

PER

Ann: Change of Director's Interest Notice - Dr James Garner

09:41

9.3K

09:41

Last post HallerLujah

9.3K

See All Discussions

Timeline

Change of Director's Interest Notice - Dr James Garner
01 Jul 08:39	Share

Ceasing to be a substantial holder from PVL
30 Jun 11:05	Share

Percheron Therapeutics Limited Corporate Presentation
27 Jun 08:25	Share

Percheron licenses HMBD-002 from Hummingbird Bioscience
26 Jun 10:18	Share

Trading Halt
25 Jun 09:35	Share

Change of Director's Interest Notice - Dr James Garner
20 May 10:33	Share

Change of Directors Interest Notice - Dr Charmaine Gittleson
20 May 10:31	Share

Notification regarding unquoted securities - PER
20 May 10:29	Share

Letter to ineligible shareholders
14 May 08:19	Share

Letter to eligible shareholders
14 May 08:19	Share

Proposed issue of securities - PER
07 May 08:32	Share

Bonus Loyalty Option Offer
07 May 08:23	Share

Quarterly Activities Report and Appendix 4C
30 Apr 09:04	Share

Results of General Meeting
24 Apr 16:56	Share

Change of Interest of Substantial Holder from PVL
22 Apr 16:52	Share

Percheron Therapeutics General Meeting
22 Apr 12:34	Share

Change of Director's Interest Notice - Dr Ben Gil Price
03 Apr 08:41	Share

Letter to Shareholders from the Board of Directors
02 Apr 08:26	Share

Change of Director's Interest Notice - Dr James Garner
31 Mar 08:25	Share

Notification of cessation of securities - PER
18 Mar 16:34	Share

Notice of General Meeting
14 Mar 13:16	Share

Notification of cessation of securities - PER
11 Mar 15:13	Share

Response to ASX Query
06 Mar 11:52	Share

Ceasing to be a substantial holder
06 Mar 09:50	Share

Results of General Meeting
04 Mar 12:13	Share

Change of Director's Interest Notice - Dr James Garner
26 Feb 16:26	Share

Notices received under S203D and S249D of Corporations Act
25 Feb 09:59	Share

Update on Partnering Progress
24 Feb 08:01	Share

Change of Interest of Substantial Holder from PVL
21 Feb 15:22	Share

Letter From The Chair and Half Year Accounts
19 Feb 11:30	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.8¢		Change 0.000(0.00%)		Mkt cap ! $8.699M

Open	High	Low	Value	Volume
0.9¢	0.9¢	0.8¢	$1.301K	156.4K

Buyers (Bids)

No.	Vol.	Price($)
27	6745374	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	1257781	6

View Market Depth

No.	Vol.	Price($)
27	6745374	0.008
6	2289427	0.007
2	1850000	0.006
4	1899797	0.005
1	1475000	0.004

Price($)	Vol.	No.
0.009	1257781	6
0.010	3648295	9
0.011	2200000	4
0.012	2658324	5
0.013	1500000	3

Last trade - 15.56pm 22/07/2025 (20 minute delay)

PER (ASX) Chart

PERCHERON THERAPEUTICS LIMITED

Latest Threads

Timeline

Featured News

Latest Articles

Percheron Therapeutics lays out expected timeline for avicursen trial data

Percheron expects to deliver topline data from its Duchenne muscular dystrophy (DMD) trial using avicursen from December 16.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News